MGV:NYE-Vanguard Mega Cap Value Index Fund ETF Shares (USD)

ETF | Large Value |

Last Closing

USD 127.95

Change

-0.07 (-0.05)%

Market Cap

N/A

Volume

0.14M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Large Value

Symbol Name Price(Change) Market Cap
SCHD Schwab U.S. Dividend Equity ET..

+0.06 (+0.07%)

USD 61.23B
DGRO iShares Core Dividend Growth E..

+0.02 (+0.03%)

USD 30.15B
FNDX Schwab Fundamental U.S. Large ..

-0.09 (-0.13%)

USD 17.02B
SCHV Schwab U.S. Large-Cap Value ET..

-0.06 (-0.07%)

USD 11.82B
SPYD SPDR® Portfolio S&P 500 High ..

-0.17 (-0.37%)

USD 6.77B
VOOV Vanguard S&P 500 Value Index F..

-0.36 (-0.19%)

USD 5.21B
FDVV Fidelity® High Dividend ETF

+0.02 (+0.04%)

USD 3.58B
SPHD Invesco S&P 500® High Dividen..

-0.23 (-0.45%)

USD 3.52B
IWX iShares Russell Top 200 Value ..

-0.01 (-0.01%)

USD 3.18B
LRGF iShares U.S. Equity Factor ETF

+0.01 (+0.02%)

USD 2.16B

ETFs Containing MGV

FDVL 8.93 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.99% 88% B+ 74% C
Dividend Return 1.97% 68% D+ 39% F
Total Return 18.96% 88% B+ 73% C
Trailing 12 Months  
Capital Gain 28.49% 60% D- 69% C-
Dividend Return 2.94% 73% C 40% F
Total Return 31.43% 65% D 68% D+
Trailing 5 Years  
Capital Gain 60.18% 67% D+ 73% C
Dividend Return 14.94% 73% C 53% F
Total Return 75.12% 69% C- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 10.68% N/A N/A 69% C-
Dividend Return 13.18% N/A N/A 70% C-
Total Return 2.50% N/A N/A 54% F
Risk Return Profile  
Volatility (Standard Deviation) 14.19% N/A N/A 66% D+
Risk Adjusted Return 92.85% N/A N/A 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike